Liver Cancer and Cannabis: Study Finds Cannabinoids Have Anti-Tumoral Effect on HCC

new report published on PubMed.gov demonstrates that cannabinoids from the marijuana plant could provide a new choice of treatment for those suffering from one of today’s deadlier forms of liver cancer.

HCC – also known as Hepatocellular Carcinoma – is one of the most common forms of liver cancer affecting men over the age of 50. Long considered to be one of the more lethal cancer-related illnesses, HCC accounts for roughly 75% of all liver cancers.

HCC, unlike metastatic liver cancer, starts and remains in the liver, and is caused by scarring within this vital organ. While there may be many root sources of this deadly scarring within the liver (a.k.a. cirrhosis of the liver), the primary players are; alcohol abuse, autoimmune diseases of the liver, and the hepatitis B or C virus.

Currently only a few viable treatment options are offered by Western medicine, but according to an...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.